The Research and Development team at Systems Oncology focuses on the innovative design and optimization of multimodal RNA therapeutics. This skilled group collaborates on synthesizing oligonucleotides, investigating immunobiological applications, and conducting experimental research to advance the understanding and effectiveness of RNA-based treatments against complex diseases, ultimately aiming to enhance patient outcomes and tackle drug resistance.
View all